EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CKMT1 Counteracts VDAC1 Oligomerization‐Induced Neuronal Pyroptosis Through Steric Hindrance in Ischemic Stroke

Xiaoyu Wang, Sai Shi iD, Jianghui Wu iD, Jingge Zhang iD, Shuqin Li, Yuyan Hu iD, Haifeng Yin iD, Chenguang Zhao iD, Dong Ma iD, Xiaohui Xian iD, Lizhe Liu iD, Ling Zhao iD und 6 weitere

Advanced Science · 05.11.2026

DOI: 10.1002/advs.78611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 05.11.2026. Verfasst von Xiaoyu Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Hebei Medical University, Shijiazhuang, People's Republic of China. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, 2025 Hebei Universities-Shijiazhuang Industry-University-Research Collaboration Project, Hengrui Hebei Innovative Development Medical Cooperation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic stroke is one of the leading causes of death and disability worldwide; yet effective therapeutic options remain limited. Cytosolic leakage of mitochondrial DNA (mtDNA) is a critical driver of ischemic brain injury. Voltage‐dependent anion channel 1 (VDAC1), embedded in the mitochondrial outer membrane, promotes mtDNA leakage through oligomerization. However, the regulatory mechanisms underlying VDAC1 oligomerization in ischemic stroke remain poorly understood. This study demonstrates that ischemic stroke promotes VDAC1 oligomerization, leading to mtDNA leakage, activating the absent in melanoma 2 (AIM2) inflammasome, and subsequent neuronal pyroptosis. Pharmacological inhibition of VDAC1 oligomerization using VBIT‐4 effectively disrupts this cascade. Creatine kinase mitochondrial 1 (CKMT1) is identified as a novel endogenous inhibitor of VDAC1 oligomerization. CKMT1 inhibits VDAC1 oligomerization through a dual‐region synergistic mechanism. Specifically, the N‐terminal domain of CKMT1 (residues R75 and E121) forms a stable interface with the C‐terminal domain of VDAC1 (residues R218 and E189), whereas the CKMT1 signal peptide (residues 1–39) sterically hinders VDAC1 dimerization, thereby blocking oligomerization. Moreover, neuronal overexpression of CKMT1 significantly attenuates neuronal apoptosis, whereas CKMT1 knockdown aggravates neuronal injury. Collectively, these findings demonstrate that CKMT1 protects against cerebral ischemic injury by suppressing the VDAC1–mtDNA–AIM2 axis and identify CKMT1 as a novel therapeutic target for ischemic stroke.

Schlagwörter

Stichwörter der Autor:innen

absent in melanoma 2 (AIM2)creatine kinase mitochondrial 1 (CKMT1)ischemic strokemitochondrial DNA (mtDNA)pyroptosisvoltage‐dependent anion channel 1 (VDAC1) oligomerization

Autor:innen und Institutionen

  • Department of Pathophysiology, Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Department of Medical and Pharmaceutical Informatics, Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Hebei Key Laboratory of Critical Disease Mechanism and Intervention, Shijiazhuang, People's Republic of China.
  • The Key Laboratory of Neural and Vascular Biology, Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Foreign Languages Department, Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Department of Biochemistry and Molecular Biology, Hebei Medical University, Shijiazhuang, People's Republic of China.

ORCID-Profile: Sai Shi, Jianghui Wu, Jingge Zhang, Yuyan Hu, Haifeng Yin, Chenguang Zhao, Dong Ma, Xiaohui Xian, Lizhe Liu, Ling Zhao, Xiyun Liu, Zhikai Yu, Lihua Dong, Wenbin Li, Lingyan Zhang, Min Zhang

Förderung

  • National Natural Science Foundation of China
  • 2025 Hebei Universities-Shijiazhuang Industry-University-Research Collaboration Project
  • Hengrui Hebei Innovative Development Medical Cooperation Program
  • Natural Science Foundation of Hebei Province
  • Science Research Project of the Hebei Education Department
  • directors' funds
  • Graduate Zhiyuan Fund

Zitieren

APA

Wang, X., Shi, S., Wu, J., Zhang, J., Li, S., Hu, Y., Yin, H., Zhao, C., Ma, D., Xian, X., Liu, L., Zhao, L., Liu, X., Yu, Z., Dong, L., Li, W., Zhang, L., & Zhang, M. (2026). CKMT1 Counteracts VDAC1 Oligomerization‐Induced Neuronal Pyroptosis Through Steric Hindrance in Ischemic Stroke. Advanced Science. https://doi.org/10.1002/advs.78611

Vancouver

Wang X, Shi S, Wu J, Zhang J, Li S, Hu Y, et al. CKMT1 Counteracts VDAC1 Oligomerization‐Induced Neuronal Pyroptosis Through Steric Hindrance in Ischemic Stroke. Advanced Science. 2026. doi:10.1002/advs.78611

BibTeX
@article{Wang2026,
  author = {Wang, Xiaoyu and Shi, Sai and Wu, Jianghui and Zhang, Jingge and Li, Shuqin and Hu, Yuyan and Yin, Haifeng and Zhao, Chenguang and Ma, Dong and Xian, Xiaohui and Liu, Lizhe and Zhao, Ling and Liu, Xiyun and Yu, Zhikai and Dong, Lihua and Li, Wenbin and Zhang, Lingyan and Zhang, Min},
  title = {CKMT1 Counteracts VDAC1 Oligomerization‐Induced Neuronal Pyroptosis Through Steric Hindrance in Ischemic Stroke},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78611}
}
Kostenlos starten →